Even through the complete metastasis-promoting event involving the combined lower expression of FIH and PHD3 still need further exploration, our result is still of high value to provide the first evidence that lower level of PHD3 and FIH may be an important co-regulator of metastasis in HCC. The gene discussed is EGLN3; the disease is hepatocellular carcinoma.